Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Niger
Niger: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati was 87.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Niger, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Niger recorded 87.0% for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in 2025. That is the highest value across all 18 years on record.
Compared with earlier readings it is up 1.2% on the previous year and up 77.6% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Niger peaked at 87.0% in 2025 and was at its lowest, 0.0%, in 2008.
That places Niger 86th out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 38.3% | 0.0% | 85.0% | 10 |
| 2020s | 84.2% | 81.0% | 87.0% | 6 |
Countries ranked near Niger
- 86 Kenya 87.0% compare
- 86 Kiribati 87.0% compare
- 86 Dominican Republic 87.0% compare
- 86 Netherlands 87.0% compare
- 86 Lithuania 87.0% compare
More health data for Niger
- Heat deaths vs projected death rates 887.5 (2090)
- Un projection of annual infant deaths 22,995 (2100)
- Deaths in armed conflicts by country 259 (2026)
- Deaths in armed conflicts by region 259 (2026)
- Age population, age 08, male, interpolated 423,756 (2025)
- Population, male 50.8% (2025)
- Age population, age 06, female, interpolated 425,555 (2025)
- Age population, age 06, male, interpolated 439,639 (2025)
- Age population, age 07, female, interpolated 417,693 (2025)
- Population ages 15-64, female 7.01 million (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Niger?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Niger was 87.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Niger?
- The highest recorded value was 87.0% in 2025.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Niger?
- The lowest recorded value was 0.0% in 2008.
- How does Niger rank for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Niger ranks 86th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati rising or falling in Niger?
- Over the last ten years it is up 77.6%. The long-run trend across the full record is volatile.
- Where does this Niger data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).